Keywords: Takeda, Financial results nine months to Dec 2009

Takeda’s 3rd quarter profits hit by in-licensing costs and sales declines for Actos and Prevacid

Article | 04 February 2010

Print This

Japan’s largest drugmaker Takeda posted results for the nine months ended December 31, 2009, reporting its first profit drop in five ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in